Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4AKY

CRYSTAL STRUCTURE OF VIRB8 FROM BRUCELLA SUIS IN COMPLEX WITH INTERACTION INHIBITOR 2-(butylamino)-8-quinolinol

Summary for 4AKY
Entry DOI10.2210/pdb4aky/pdb
Related2BHM 4AKZ
DescriptorTYPE IV SECRETION SYSTEM PROTEIN VIRB8, 2-(butylamino)quinolin-8-ol (3 entities in total)
Functional Keywordstransport protein, bacterial type iv secretion
Biological sourceBRUCELLA SUIS
Cellular locationCell inner membrane; Single-pass membrane protein (Potential): Q7CEG3
Total number of polymer chains5
Total formula weight78761.93
Authors
Coincon, M.,Smith, M.A.,Sygusch, J.,Baron, C. (deposition date: 2012-02-29, release date: 2012-09-05, Last modification date: 2023-12-20)
Primary citationSmith, M.A.,Coincon, M.,Paschos, A.,Jolicoeur, B.,Lavallee, P.,Sygusch, J.,Baron, C.
Identification of the Binding Site of Brucella Virb8 Interaction Inhibitors.
Chem.Biol., 19:1041-, 2012
Cited by
PubMed Abstract: Secretion systems translocate virulence factors of many bacterial pathogens, enabling their survival inside the host organism. Consequently, inhibition strongly attenuates pathogenicity and can be considered a target for novel antimicrobial drugs. The type IV secretion system (T4SS) of the intracellular pathogen Brucella is a prerequisite for its virulence, and in this work we targeted the interactions of the essential assembly factor protein, VirB8, using small-molecule inhibitors. High-throughput screening identified several potent and specific inhibitors, and the target-binding site of these inhibitors was identified by X-ray crystallography, in silico docking, and analysis of the derivates of the inhibitor B8I-2. VirB8 interaction inhibitors bind to a surface groove opposite to the dimerization interface, and by varying the binding-site residues, we were able to determine which residues are required for inhibitor activity. E115 and K182 were found to be especially important, and changes at R114, Y229, and L151 also reduced inhibitor efficiency.
PubMed: 22921071
DOI: 10.1016/J.CHEMBIOL.2012.07.007
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon